[Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review]
- PMID: 15058760
[Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review]
Abstract
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease, which may afflict as many as 1 in 500 subjects (0.2%), being probably the most common hereditary cardiovascular disease and the most common cause of sudden cardiac death (SCD). Hypertrophic cardiomyopathy is characterized by the presence of unexplained left ventricular hypertrophy (in absence of hypertension, valvular disease, etc), which is usually asymmetric and involves the ventricular septum. Molecular genetic studies have identified eleven genes that code proteins of the sarcomere that are associated with the HCM; the beta-myosin heavy chain gene (MYH7), alpha-myosin heavy chain (MYH6), cardiac troponin T (TNNT2); cardiac troponin C (TNNC1), alpha-tropomyosin (TPM1), myosin binding protein-C (MYBPC3), cardiac troponin (TNNI3), essential and regulatory light chain genes (MYL3 and MYL2, respectively), cardiac alpha-actin gene (ACTC) and titin (TTN). The objective of this paper is the revision of the current state of the knowledge on (1) the organization and mutations of the HCM causing genes and their proteins and (2) the animal models developed for the study of the genes, mutations and proteins in the hypertrophic cardiomyopathy.
Similar articles
-
Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.Am Heart J. 2006 Mar;151(3):725.e1-725.e9. doi: 10.1016/j.ahj.2005.12.005. Am Heart J. 2006. PMID: 16504640
-
Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.J Am Coll Cardiol. 2010 Apr 6;55(14):1444-53. doi: 10.1016/j.jacc.2009.11.062. J Am Coll Cardiol. 2010. PMID: 20359594
-
A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.J Cardiovasc Med (Hagerstown). 2006 Aug;7(8):601-7. doi: 10.2459/01.JCM.0000237908.26377.d6. J Cardiovasc Med (Hagerstown). 2006. PMID: 16858239
-
[Mutations in genes for sarcomeric proteins].Nihon Rinsho. 2000 Jan;58(1):117-22. Nihon Rinsho. 2000. PMID: 10885298 Review. Japanese.
-
[Genetic changes and clinical management in familial hypertrophic cardiomyopathy].Wiad Lek. 2000;53(1-2):4-21. Wiad Lek. 2000. PMID: 10806915 Review. Polish.
Cited by
-
Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children with Myocardial Changes.Biomolecules. 2024 Apr 13;14(4):477. doi: 10.3390/biom14040477. Biomolecules. 2024. PMID: 38672493 Free PMC article. Review.
-
Contractility of ventricular myocytes is well preserved despite altered mechanisms of Ca2+ transport and a changing pattern of mRNA in aged type 2 Zucker diabetic fatty rat heart.Mol Cell Biochem. 2012 Feb;361(1-2):267-80. doi: 10.1007/s11010-011-1112-y. Epub 2011 Oct 19. Mol Cell Biochem. 2012. PMID: 22009485
-
Fluorene-9-bisphenol affects the terminal differentiation of mouse embryonic bodies.Curr Res Toxicol. 2023 Nov 2;5:100133. doi: 10.1016/j.crtox.2023.100133. eCollection 2023. Curr Res Toxicol. 2023. PMID: 37964943 Free PMC article.
-
Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant.Heliyon. 2022 Dec 16;8(12):e12373. doi: 10.1016/j.heliyon.2022.e12373. eCollection 2022 Dec. Heliyon. 2022. PMID: 36593836 Free PMC article.
-
Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq.Int J Mol Sci. 2020 Apr 25;21(9):3040. doi: 10.3390/ijms21093040. Int J Mol Sci. 2020. PMID: 32344918 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous